Curative effect of simultaneous chemo-radiotherapy for nasopharyngeal carcinoma in late course radiotherapy
Gong Le-min
Abstract
Gong Le-min
Abstract
[Objective] To observe the effect of local control rate, survival rate, distant metastasis rate and the acute reaction of oral and pharynx membrane to x-ray in simultaneous chemo-radiotherapy for nasopharyngeal carcinoma in late course of radiotherapy. [Methods] From March 1998 to March 2002, 78 patients with histologically proved nasopharyngeal carcinoma (stage Ⅲ, Ⅳa) were randomized into two groups. Group A (control group) received chemotherapy combined with radiotherapy one cycle (DF method) and then routine radiotherapy. It finally received another assistant chemotherapy 2 to 3 cycles. Group B was based on the same therapy and added chemotherapy combined with radiotherapy one cycle just after finishing the radiotherapy on the face combined with neck. [Result] The 3-year primary tumor and cervical node control rate in group B was 10% higher than that in group A, and they were 76.92% vs 66.67% (P 0.05) and 76.92% vs 64.10% (P 0.05) respectively. The 3-year survival rate in two groups were 74.35% vs 71.80% (P 0.05). The distant metastasis in group A and group B were 23.08%, 25.64% (P 0.05) respectively. The reactions of the oral and pharynx membrane were little different compared group A with group B. [Conclusion] The upper radiotherapy combined with chemotherapy may increase 3-year local disease control rate in patient with nasopharyngeal carcinoma at stage Ⅲ, Ⅳ a.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
[Objective] To observe the effect of local control rate, survival rate, distant metastasis rate and the acute reaction of oral and pharynx membrane to x-ray in simultaneous chemo-radiotherapy for nasopharyngeal carcinoma in late course of radiotherapy. [Methods] From March 1998 to March 2002, 78 patients with histologically proved nasopharyngeal carcinoma (stage Ⅲ, Ⅳa) were randomized into two groups. Group A (control group) received chemotherapy combined with radiotherapy one cycle (DF method) and then routine radiotherapy. It finally received another assistant chemotherapy 2 to 3 cycles. Group B was based on the same therapy and added chemotherapy combined with radiotherapy one cycle just after finishing the radiotherapy on the face combined with neck. [Result] The 3-year primary tumor and cervical node control rate in group B was 10% higher than that in group A, and they were 76.92% vs 66.67% (P 0.05) and 76.92% vs 64.10% (P 0.05) respectively. The 3-year survival rate in two groups were 74.35% vs 71.80% (P 0.05). The distant metastasis in group A and group B were 23.08%, 25.64% (P 0.05) respectively. The reactions of the oral and pharynx membrane were little different compared group A with group B. [Conclusion] The upper radiotherapy combined with chemotherapy may increase 3-year local disease control rate in patient with nasopharyngeal carcinoma at stage Ⅲ, Ⅳ a.
Key concepts: Medicine, Radiation therapy, Nasopharyngeal carcinoma, Chemotherapy, Pharynx, Stage (stratigraphy), Survival rate, Carcinoma